Pediatrix Medical Group (NYSE:MD) Cut to Underperform at Mizuho

Mizuho lowered shares of Pediatrix Medical Group (NYSE:MD) from a neutral rating to an underperform rating in a research note published on Wednesday morning, Marketbeat reports. Mizuho currently has $28.00 price objective on the stock.

A number of other brokerages also recently commented on MD. Wall Street Zen raised Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research report on Sunday, September 13th. Jefferies Financial Group lowered shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and upped their target price for the stock from $27.00 to $28.00 in a research note on Wednesday, August 19th. Deutsche Bank reaffirmed a “hold” rating and issued a $25.00 target price on shares of Pediatrix Medical Group in a report on Wednesday, August 5th. Truist Financial lifted their price target on shares of Pediatrix Medical Group from $28.00 to $31.00 and gave the stock a “hold” rating in a research note on Friday, October 30th. Finally, Weiss Ratings upgraded shares of Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, September 9th. One equities research analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $28.00.

Pediatrix Medical Group Trading Down 0.1%

NYSE:MD opened at $31.35 on Wednesday. Pediatrix Medical Group has a 12-month low of $17.23 and a 12-month high of $33.74. The firm has a market cap of $2.45 billion, a PE ratio of 17.04 and a beta of 0.62. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 0.47. The stock has a fifty day moving average price of $27.88 and a 200 day moving average price of $24.34.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Thursday, October 29th. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.65 by $0.07. The company had revenue of $501.37 million for the quarter, compared to the consensus estimate of $498.18 million. Pediatrix Medical Group had a return on equity of 20.12% and a net margin of 7.66%. Pediatrix Medical Group’s revenue was up 1.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.67 EPS. Sell-side analysts anticipate that Pediatrix Medical Group will post 2.23 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in MD. Empowered Funds LLC increased its holdings in shares of Pediatrix Medical Group by 15.9% in the 3rd quarter. Empowered Funds LLC now owns 579,392 shares of the company’s stock valued at $14,908,000 after acquiring an additional 79,274 shares during the last quarter. First Trust Advisors LP raised its position in shares of Pediatrix Medical Group by 5.1% during the 3rd quarter. First Trust Advisors LP now owns 194,353 shares of the company’s stock worth $5,001,000 after acquiring an additional 9,445 shares in the last quarter. Public Sector Pension Investment Board raised its position in shares of Pediatrix Medical Group by 5.9% during the 3rd quarter. Public Sector Pension Investment Board now owns 1,045,698 shares of the company’s stock worth $27,842,000 after acquiring an additional 57,838 shares in the last quarter. Global Retirement Partners LLC raised its position in shares of Pediatrix Medical Group by 605.9% during the 3rd quarter. Global Retirement Partners LLC now owns 9,198 shares of the company’s stock worth $237,000 after acquiring an additional 7,895 shares in the last quarter. Finally, Edgestream Partners L.P. purchased a new stake in Pediatrix Medical Group during the third quarter worth approximately $5,138,000. 97.71% of the stock is owned by institutional investors and hedge funds.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group provides physician services to hospitals and other healthcare facilities across the United States. Its clinicians care for women, newborns and children, working with healthcare partners to support patients in hospital and other clinical settings. The company’s services include neonatal care, maternal-fetal medicine and pediatric subspecialties. Its physicians and advanced practice providers deliver care such as treatment for high-risk pregnancies and specialized medical services for newborns and children.